Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain. (Q40791154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Shigella boydii

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Soma Mitra

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ritam Sinha

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hemanta Koley

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

12 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1839-1846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

Estimating child mortality due to diarrhoea in developing countries

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Immunology of Gut Mucosal Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Growing antimicrobial resistance of Shigella isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Biological functions and biogenesis of secreted bacterial outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

The tol gene products and the import of macronmolecules into Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Improved methods for producing outer membrane vesicles in Gram-negative bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Deletion of tolA in Salmonella Typhimurium generates an attenuated strain with vaccine potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Application of lambda Red recombination system to Vibrio cholerae genetics: simple methods for inactivation and modification of chromosomal genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

A Colorimetric Method for the Determination of Sugars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Colorimetric Method for Determination of Sugars and Related Substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Role of CD3ε-mediated signaling in T-cell development and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Role of the CD28 receptor in T-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

The excC gene of Escherichia coli K-12 required for cell envelope integrity encodes the peptidoglycan-associated lipoprotein (PAL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

The TolQ-TolR proteins energize TolA and share homologies with the flagellar motor proteins MotA-MotB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

The Tol/Pal system function requires an interaction between the C-terminal domain of TolA and the N-terminal domain of TolB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

T cell stimulation in vivo by lipopolysaccharide (LPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Stressor-induced increase in microbicidal activity of splenic macrophages is dependent upon peroxynitrite production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Induction of IFN-gamma in macrophages by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Effects of LPS-mediated bystander activation in the innate immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Directing transition from innate to acquired immunity: defining a role for IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

High yield production process for Shigella outer membrane particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

Escherichia coli tol-pal mutants form outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.02.018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26878295%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference